Carbamazepine Alternatives Compared
| Carbamazepine | Gabapentin | Tegretol |
|
|---|
| Carbamazepine | Gabapentin | Tegretol carbamazepine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Carbamazepine is an anticonvulsant that may be used in the treatment of various seizure disorders and also to relieve nerve pain associated with conditions such as trigeminal neuralgia or diabetic... View more |
Gabapentin may be used in the treatment of partial-onset seizures and nerve pain but is likely to cause dizziness or drowsiness. Gabapentin enacarbil (brand name Horizant), a prodrug of gabapentin... View more |
Prescribed for Trigeminal Neuralgia, Schizoaffective Disorder, Epilepsy. Tegretol may also be used for purposes not listed in this medication guide. |
Choose a suggestion below Epilepsy
Trigeminal Neuralgia
|
|||||||||||||||||||||||
| More about Carbamazepine | More about Gabapentin | More about Tegretol (carbamazepine) | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Carbamazepine has an average rating of 6.8 out of 10 from a total of 312 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 22% reported a negative effect. |
Gabapentin has an average rating of 7.1 out of 10 from a total of 2312 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. |
Tegretol has an average rating of 6.8 out of 10 from a total of 75 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Commonly reported side effects include: ataxia, dizziness, drowsiness, nausea, vomiting. See the full carbamazepine side effects document. |
Commonly reported side effects include: ataxia, dizziness, drowsiness, fatigue, fever, nystagmus disorder, sedated state, viral infection. See the full gabapentin side effects document. |
See the full Tegretol side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all carbamazepine prices |
View all gabapentin prices |
View all Tegretol prices and generic prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR | Fanatrex, Gabarone, Gralise, Neurontin | Other carbamazepine brands include: Carbatrol, Epitol, Equetro, Tegretol XR | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
19 hours |
6 hours |
19 hours |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 716 drugs are known to interact with carbamazepine:
|
A total of 264 drugs are known to interact with gabapentin:
|
A total of 716 drugs are known to interact with Tegretol:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
March 11, 1968 |
December 30, 1993 |
March 11, 1968 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.